ArticleHealth science reports2025
The Effect of Hypnotherapy on the Resilience of Women With Polycystic Ovarian Syndrome: Study Protocol for a Randomized Controlled Trial.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Effect of Hypnotherapy on the Resilience of Women With Polycystic Ovarian Syndrome: Study Protocol for a Randomized Controlled Trial.Health science reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Polycystic ovarian syndrome, with a mean incidence of 5-10, is the most common endocrine disorder affecting women of reproductive age. These patients suffer from a wide range of symptoms that are inversely related to their resilience and quality of life. Thus, this study protocol was prepared to determine the effect of hypnotherapy intervention on the resilience of patients with polycystic ovary syndrome. Methods: The current study protocol is a randomized clinical trial. In total, 56 women diagnosed with polycystic ovarian syndrome will be invited to participate in a 6-week intervention. After allocating the samples to two control and intervention groups using a block randomized design, for each subject in the intervention group, 6 weekly sessions of hypnotherapy will be held for 40-60 min, and for the control group, routine care will be provided. In this study, the level of patient resilience will be measured as the primary outcome using the Connor-Davidson Resilience Scale (CD-RIS). Analysis will be conducted using SPSS V.26. To compare variables between intervention and control groups according to the qualitatively and quantitatively variable nature, the Discussion: This plan focuses on the resilience and quality of life in women with polycystic ovarian syndrome. Considering that hypnotherapy is safe and relatively inexpensive, and has almost no side effects, it is very important to determine whether women with polycystic ovary syndrome could benefit from this psychological technique. Trial Registration: Iranian Clinical Trial Register IRCT20161126031117N12; Registered V1.0 on May 4, 2022.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.